Kyle A. Lefkoff
life sciences
Array Bio Pharma Inc
United States of America
Biography
Mr. Lefkoff has served as Chairman of the Board of Directors from May 1998 to January 2012, and was again appointed Chairman in April 2012 and still serves in that role. From January to April 2012, Mr. Lefkoff served as Executive Chairman on an interim basis pending appointment of a new Chief Executive Officer for Array. Since 1995, Mr. Lefkoff has been a General Partner of Boulder Ventures Limited, a venture capital firm and a prior investor in Array. In his thirty-year career as a venture capitalist, Mr. Lefkoff has invested in 57 Colorado companies, resulting in fourteen Initial Public Offerings and fifteen trade sales. From 1986 until 1995, Mr. Lefkoff was employed by Colorado Venture Management, a venture capital firm. Mr. Lefkoff serves on the Board of Directors for miRagen Therapeutics, MarketForce Information, Black Bear Energy and CommercialTribe. Mr. Lefkoff received a B.A. in economics from Vassar College and an M.B.A. in finance from the University of Chicago.
Research Interest
Mr. Lefkoff has served as Chairman of the Board of Directors from May 1998 to January 2012, and was again appointed Chairman in April 2012 and still serves in that role. From January to April 2012, Mr. Lefkoff served as Executive Chairman on an interim basis pending appointment of a new Chief Executive Officer for Array. Since 1995, Mr. Lefkoff has been a General Partner of Boulder Ventures Limited, a venture capital firm and a prior investor in Array. In his thirty-year career as a venture capitalist, Mr. Lefkoff has invested in 57 Colorado companies, resulting in fourteen Initial Public Offerings and fifteen trade sales. From 1986 until 1995, Mr. Lefkoff was employed by Colorado Venture Management, a venture capital firm. Mr. Lefkoff serves on the Board of Directors for miRagen Therapeutics, MarketForce Information, Black Bear Energy and CommercialTribe. Mr. Lefkoff received a B.A. in economics from Vassar College and an M.B.A. in finance from the University of Chicago.